The UV research groups (GIUV) are regulated in the 1st chapter of the Regulation ACGUV48/2013, which explains the procedure for creating new research structures. They are basic research and organizational structures that result from the voluntary association of researchers that share objectives, facilities, resources and common lines of research. These researchers are also committed to the consolidation and stability of their activity, work in groups and the capability to achieve a sustainable funding.

The research groups included in the previously mentioned Regulation are registered in the Register of Research Structures of the Universitat de València (REIUV), managed by the Office of the Vice-principal for Research and Scientific Policies. The basic information of these organisms can be found in this website.

Participants

Data related to research groups featured in various information dissemination channels shall not, under any circumstances, imply a statement or commitment regarding the employment or academic affiliation of individuals associated with the Universitat de València. Their inclusion is solely the responsibility of the group directors. Updates will be made upon request from interested parties.

  • Registered groups in the Register of Research Structures of the Universitat de València - (REIUV)

Research Group on Inflammasome and Cell Death Signaling - INFDeath

Reference of the Group:

GIUV2026-038

 
Description of research activity:
The Inflammasome Signaling and Cell Death Research Group aims to investigate the molecular mechanisms that regulate inflammasome activation and their interplay with distinct cell death programs, as well as their contribution to the pathophysiology of inflammatory and tumor-related diseases. Inflammasomes are multiprotein complexes of the innate immune system that assemble in response to cellular damage or stress signals (DAMPs and PAMPs) and function as signaling platforms for caspase-1 activation. Canonically, these complexes are composed of a sensor receptor, an adaptor protein ASC (Apoptosis-associated speck-like protein containing a CARD) and procaspase-1. Activation of caspase-1 leads to the processing of proinflammatory cytokines such as IL-1b and IL-18, as well as the cleavage of gasdermin D, thereby triggering pore formation in the plasma membrane and cell death by pyroptosis. Although multiple inflammasomes have been described depending on the initiating sensor receptor and have been implicated in a wide range of pathologies, current knowledge has largely focused on the NLRP3 inflammasome, while others such as NLRP6 or AIM2 remain less characterized. In this context, the...The Inflammasome Signaling and Cell Death Research Group aims to investigate the molecular mechanisms that regulate inflammasome activation and their interplay with distinct cell death programs, as well as their contribution to the pathophysiology of inflammatory and tumor-related diseases. Inflammasomes are multiprotein complexes of the innate immune system that assemble in response to cellular damage or stress signals (DAMPs and PAMPs) and function as signaling platforms for caspase-1 activation. Canonically, these complexes are composed of a sensor receptor, an adaptor protein ASC (Apoptosis-associated speck-like protein containing a CARD) and procaspase-1. Activation of caspase-1 leads to the processing of proinflammatory cytokines such as IL-1b and IL-18, as well as the cleavage of gasdermin D, thereby triggering pore formation in the plasma membrane and cell death by pyroptosis. Although multiple inflammasomes have been described depending on the initiating sensor receptor and have been implicated in a wide range of pathologies, current knowledge has largely focused on the NLRP3 inflammasome, while others such as NLRP6 or AIM2 remain less characterized. In this context, the group focuses on the identification of chemical modulators capable of regulating the activation of inflammasomes such as NLRP6 and AIM2, as well as on their functional characterization. To this end, the group combines high-throughput screening strategies, recombinant protein production, and mechanistic studies in cellular models, complemented by inflammatory in vivo models as proof of concept. In addition, these approaches allow exploration of the specific contribution of these inflammasomes to complex diseases, including cancer. In parallel, the laboratory is also interested in the study of the adaptor protein ASC, based on the principal investigator¿s previous experience in the development of the ASC-specific inhibitor MM01. Beyond its role as an essential intracellular adaptor for caspase-1 activation, ASC forms filamentous structures with prion-like properties that organize into so-called ASC specks. The group investigates both the value of ASC as a biomarker in inflammatory diseases and the role of extracellular ASC specks released upon inflammasome activation, which act as potent amplifiers of inflammatory signaling and contribute to the propagation of inflammation between cells and tissues. In this regard, ASC is conceived not only as a molecular scaffold but also as a multimodal platform at the crossroads of inflammation, apoptosis, autophagy, and antiviral signaling pathways. Finally, a transversal line of research addresses the crosstalk between inflammasomes and distinct regulated cell death programs, including pyroptosis and apoptosis. The goal is to understand how the activation of these signaling platforms determines cell fate and how modulation of these processes may open new therapeutic opportunities. Overall, the group aims to contribute to a global understanding of inflammasome signaling and cell death by identifying novel regulatory nodes and providing experimental evidences for the development of therapeutic strategies aimed at modulating the innate inflammatory response.
[Read more][Hide]
 
Web:

No determinada

 
Scientific-technical goals:
  • Study the involvement of inflammasomes in inflammatory diseases and cancer.
  • Identify modulators of different inflammasomes, with particular emphasis on the NLRP6 and AIM2 inflammasomes.
  • Explore the role of ASC as a biomarker, with a specific focus on analyzing the behavior of ASC specks as propagators of the inflammatory process.
 
Research lines:
  • Interplay between inflammasome activation and cell death.Analyze the interplay between inflammasome activation and distinct cell death programs, including pyroptosis and apoptosis, with the aim of understanding how these pathways converge and determine cell fate in relevant pathophysiological contexts.
  • Characterize the activation mechanisms of inflammasomes.Characterize the mechanisms of inflammasome activation, with a particular focus on NLRP6 and AIM2, through the identification of novel chemical modulators and their functional analysis in cellular and in vivo models, in order to understand their contribution to inflammatory and pathological processes, including cancer.
  • Role of the ASC adaptor protein in inflammatory signaling.Investigate the role of the adaptor protein ASC in inflammatory signaling, with special emphasis on the study of ASC specks as amplifiers and propagators of inflammation, as well as on their potential use as disease biomarkers.
 
Group members:
Name Nature of participation Entity Description
MONICA SANCHO MEDINADirectorUniversitat de València
Research team
MARIA DEL MAR ORZAEZ CALATAYUDCollaboratorUniversitat de València
MARIA DEL MAR ORZAEZ CALATAYUDCollaboratorUniversitat de València
CELIA PILAR MARTINEZ JIMENEZCollaboratorUniversitat de València
 
CNAE:
  • -
 
Associated structure:
  • Biochemistry and Molecular Biology
 
Keywords:
  • Cancer
  • INFLAMMATORY PROCESSES
  • INFLAMMATORY MEDIATORS
  • ANTITUMOUR ACTION
  • CELLULAR AND MOLECULAR MECHANISMS
  • INFLAMMATION